PTC Therapeutics, Inc.
PTCT
$50.57
$1.653.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.00B | 2.04B | 1.15B | 1.02B | 1.09B |
| Total Receivables | 196.13M | 210.50M | 158.55M | 199.98M | 187.15M |
| Inventory | 34.06M | 21.68M | 23.19M | 35.67M | 31.83M |
| Prepaid Expenses | 42.85M | 46.42M | 22.93M | 22.52M | 45.64M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 7.40M | -- | -- |
| Total Current Assets | 2.27B | 2.32B | 1.37B | 1.28B | 1.36B |
|
|
|||||
| Total Current Assets | 2.27B | 2.32B | 1.37B | 1.28B | 1.36B |
| Net Property, Plant & Equipment | 113.35M | 116.78M | 117.66M | 122.64M | 123.12M |
| Long-term Investments | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Goodwill | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Total Other Intangibles | 143.81M | 118.45M | 118.79M | 330.37M | 329.88M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.78M | 21.42M | 20.70M | 25.34M | 23.10M |
| Total Assets | 2.63B | 2.66B | 1.71B | 1.84B | 1.92B |
|
|
|||||
| Total Accounts Payable | 26.51M | 15.15M | 17.27M | 13.29M | 24.28M |
| Total Accrued Expenses | 244.21M | 219.14M | 261.62M | 301.66M | 260.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 279.10M | 264.75M | 271.18M | 274.37M | 271.00M |
| Total Finance Division Other Current Liabilities | 77.99M | 96.35M | 30.90M | 21.40M | 53.89M |
| Total Other Current Liabilities | 77.99M | 96.35M | 30.90M | 21.40M | 53.89M |
| Total Current Liabilities | 627.81M | 595.39M | 580.98M | 610.71M | 609.80M |
|
|
|||||
| Total Current Liabilities | 627.81M | 595.39M | 580.98M | 610.71M | 609.80M |
| Long-Term Debt | 2.12B | 2.14B | 2.11B | 2.11B | 2.11B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 85.07M | 87.39M | 90.52M | 98.34M | 94.69M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.82M | 22.43M | 22.23M | 77.99M | 77.35M |
| Total Liabilities | 2.84B | 2.84B | 2.80B | 2.90B | 2.90B |
|
|
|||||
| Common Stock & APIC | 2.63B | 2.61B | 2.57B | 2.53B | 2.51B |
| Retained Earnings | -2.85B | -2.78B | -3.65B | -3.58B | -3.47B |
| Treasury Stock & Other | 7.36M | -13.95M | -25.89M | -4.34M | -16.50M |
| Total Common Equity | -206.55M | -185.76M | -1.10B | -1.05B | -980.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -206.55M | -185.76M | -1.10B | -1.05B | -980.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -206.55M | -185.76M | -1.10B | -1.05B | -980.18M |
|
|
|||||